Holen Sie sich die Stockscreener-App
10.20
5.05%
0.49
Handel nachbörslich:
10.00
-0.20
-1.96%
Schlusskurs vom Vortag:
$9.71
Offen:
$9.83
24-Stunden-Volumen:
669.89K
Relative Volume:
1.40
Marktkapitalisierung:
$538.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-197.68M
KGV:
-2.7128
EPS:
-3.76
Netto-Cashflow:
$-158.88M
1W Leistung:
-3.50%
1M Leistung:
+82.80%
6M Leistung:
+129.21%
1J Leistung:
+280.60%
1-Tages-Spanne:
$9.62
$10.39
1-Wochen-Bereich:
$8.77
$11.29
52-Wochen-Spanne:
$1.92
$11.60
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1200 PAGE MILL RD, PALO ALTO, CA
Vergleichen Sie KOD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
10.20 | 594.24M | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-14 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Kodiak Sciences Inc.'s (NASDAQ:KOD) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Yahoo Finance
Volatility clustering patterns for Kodiak Sciences Inc.2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Risk vs reward if holding onto Kodiak Sciences Inc.Market Trend Report & Capital Efficiency Focused Strategies - Newser
Using R and stats models for Kodiak Sciences Inc. forecastingBond Market & Real-Time Stock Entry Alerts - Newser
Price action breakdown for Kodiak Sciences Inc.2025 Retail Activity & Real-Time Volume Analysis - Newser
Long term hold vs stop loss in Kodiak Sciences Inc.2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Volume spikes in Kodiak Sciences Inc. stock – what they meanAnalyst Downgrade & High Conviction Buy Zone Alerts - Newser
Trend analysis for Kodiak Sciences Inc. this weekMarket Movement Recap & AI Powered Market Entry Strategies - Newser
Can volume confirm reversal in Kodiak Sciences Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - Newser
How to integrate Kodiak Sciences Inc. into portfolio analysis toolsJuly 2025 Sentiment & Fast Momentum Entry Tips - Newser
Technical signs of recovery in Kodiak Sciences Inc.Buy Signal & Breakout Confirmation Trade Signals - Newser
Kodiak Sciences to Present at American Chemical Society Fall 2025 - MarketScreener
What does recent volatility data suggest for Kodiak Sciences Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - Newser
How to recover losses in Kodiak Sciences Inc. stock2025 Market WrapUp & Safe Capital Preservation Plans - Newser
What MACD and RSI say about Kodiak Sciences Inc.Trade Risk Report & Free High Return Stock Watch Alerts - Newser
Is Kodiak Sciences Inc. stock entering bullish territoryPortfolio Update Report & Free Risk Controlled Daily Trade Plans - Newser
Kodiak Sciences stock price target raised to $5 from $3 at H.C. Wainwright - Investing.com
Analysts Divided on Akero Therapeutics and Kodiak Sciences: AKRO and KOD Ratings Revealed - AInvest
Kodiak Sciences: HC Wainwright Raises PT to $5, Maintains Neutral Rating - AInvest
Key metrics from Kodiak Sciences Inc.’s quarterly dataMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser
Is Kodiak Sciences Inc. stock forming a cup and handleCEO Change & Stepwise Entry/Exit Trade Alerts - classian.co.kr
Kodiak Sciences Beats Q2 Loss Estimates - AOL.com
Forecasting Kodiak Sciences Inc. price range with options data2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
What high frequency data says about Kodiak Sciences Inc.Free AI Powered High Return Stock Calls - Newser
Will Kodiak Sciences Inc. stock benefit from interest rate changesGold Moves & AI Forecast Swing Trade Picks - Newser
Real time pattern detection on Kodiak Sciences Inc. stockBond Market & Smart Investment Allocation Insights - Newser
Why Kodiak Sciences Inc. stock attracts strong analyst attentionPortfolio Gains Report & High Return Trade Guides - thegnnews.com
Kodiak Sciences Q2 2025 Earnings: Net Loss Increases, Clinical Progress and Digital Health Initiatives Highlighted - AInvest
JP Morgan Upgrades Kodiak Sciences (KOD) to Neutral with New Price Target of $15.00 - AInvest
Barclays Raises Kodiak Sciences Price Target to $7.00, Maintains 'Underweight' Rating - AInvest
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus - MSN
XTX Topco Ltd Acquires New Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World
How to build a custom watchlist for Kodiak Sciences Inc.2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Kodiak Sciences (KOD) up more than 100% since Jul 22 - AInvest
Kodiak Q2 Loss Wider Than Expected, Pipeline Development In Focus - Barchart.com
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):